miRNA Signature of Mouse Helper T Cell Hyper-Proliferation

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Sommers, Connie L ^a,b   Rouquette Jazdanian, Alexandre K ^a   Robles, Ana I ^a   Kortum, Robert L ^a   Merrill, Robert K ^a   Li, Wenmei ^a   Nath, Nandan ^a   Wohlfert, Elizabeth ^b   Sixt, Katherine M ^a   Belkaid, Yasmine ^b   Samelson, Lawrence E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 142 3P; MICRORNA 148A; MICRORNA 150; MICRORNA 155; MICRORNA 15B; MICRORNA 16; MICRORNA 466A; MICRORNA 466B; MICRORNA 669F; PHENYLALANINE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELL SELECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENE; GENE EXPRESSION REGULATION; HELIGMOSOMOIDES POLYGYRUS; HELPER CELL; HETEROZYGOSITY; HOMEOSTASIS; LAT GENE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; NEMATODIASIS; NONHUMAN; PHENOTYPE; PROTEIN FOLDING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; GENE EXPRESSION PROFILING; HOMEOSTASIS; MICE; MICE, INBRED C57BL; MICRORNAS; NEMATOSPIROIDES DUBIUS; T-LYMPHOCYTES, HELPER-INDUCER;

MUS;

EID: 84879348000     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066709     Document Type: Article

References (49)

1. Sprent J, Surh CD, (2011) Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells. Nat Immunol 12: 478-484.
2. Yolcu ES, Ash S, Kaminitz A, Sagiv Y, Askenasy N, et al. (2008) Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression. Immunol Cell Biol 86: 650-658.
3. Josefowicz SZ, Lu LF, Rudensky AY, (2012) Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 30: 531-564.
4. Sommers CL, Park CS, Lee J, Feng C, Fuller CL, et al. (2002) A LAT mutation that inhibits T cell development yet induces lymphoproliferation. Science 296: 2040-2043.
5. Aguado E, Richelme S, Nunez-Cruz S, Miazek A, Mura AM, et al. (2002) Induction of T helper type 2 immunity by a point mutation in the LAT adaptor. Science 296: 2036-2040.
6. Miyaji M, Kortum RL, Surana R, Li W, Woolard KD, et al. (2009) Genetic evidence for the role of Erk activation in a lymphoproliferative disease of mice. Proc Natl Acad Sci U S A 106: 14502-14507.
7. Kortum RL, Rouquette-Jazdanian AK, Miyaji M, Merrill RK, Markegard E, et al. (2013) A phospholipase C-gamma1-independent, RasGRP1-ERK-dependent pathway drives lymphoproliferative disease in linker for activation of T cells-Y136F mutant mice. J Immunol 190: 147-158.
8. Rouquette-Jazdanian AK, Sommers CL, Kortum RL, Morrison DK, Samelson LE, (2012) LAT-independent Erk activation via Bam32-PLC-gamma1-Pak1 complexes: GTPase-independent Pak1 activation. Mol Cell 48: 298-312.
9. Moxham VF, Karegli J, Phillips RE, Brown KL, Tapmeier TT, et al. (2008) Homeostatic proliferation of lymphocytes results in augmented memory-like function and accelerated allograft rejection. J Immunol 180: 3910-3918.
10. Boyman O, Letourneau S, Krieg C, Sprent J, (2009) Homeostatic proliferation and survival of naive and memory T cells. Eur J Immunol 39: 2088-2094.
11. Restifo NP, Dudley ME, Rosenberg SA, (2012) Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol 12: 269-281.
12. Wang Y, Kissenpfennig A, Mingueneau M, Richelme S, Perrin P, et al. (2008) Th2 lymphoproliferative disorder of LatY136F mutant mice unfolds independently of TCR-MHC engagement and is insensitive to the action of Foxp3+ regulatory T cells. J Immunol 180: 1565-1575.
13. Mingueneau M, Roncagalli R, Gregoire C, Kissenpfennig A, Miazek A, et al. (2009) Loss of the LAT adaptor converts antigen-responsive T cells into pathogenic effectors that function independently of the T cell receptor. Immunity 31: 197-208.
14. Maizels RM, Hewitson JP, Murray J, Harcus YM, Dayer B, et al. (2012) Immune modulation and modulators in Heligmosomoides polygyrus infection. Exp Parasitol 132: 76-89.
15. Muljo SA, Kanellopoulou C, Aravind L, (2012) MicroRNA targeting in mammalian genomes: genes and mechanisms. Wiley Interdiscip Rev Syst Biol Med 2: 148-161.
16. Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, et al. (2011) miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 208: 1189-1201.
17. Tomankova T, Petrek M, Gallo J, Kriegova E, (2012) MicroRNAs: emerging regulators of immune-mediated diseases. Scand J Immunol. 75: 129-141.
18. Jansson MD, Lund AH, (2012) MicroRNA and cancer. Mol Oncol. 6: 590-610.
19. Zhang W, Sommers CL, Burshtyn DN, Stebbins CC, DeJarnette JB, et al. (1999) Essential role of LAT in T cell development. Immunity 10: 323-332.
20. Grainger JR, Smith KA, Hewitson JP, McSorley HJ, Harcus Y, et al. (2010) Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-beta pathway. J Exp Med 207: 2331-2341.
21. Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, et al. (2007) miRNA profiling of naive, effector and memory CD8 T cells. PLoS One 2: e1020.
22. Kortum RL, Rouquette-Jazdanian AK, Samelson LE (2013) Ras and extracellular signal-regulated kinase signaling in thymocytes and T cells. Trends Immunol. in press.
23. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, et al. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984.
24. Pan W, Zhu S, Yuan M, Cui H, Wang L, et al. (2010) MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 184: 6773-6781.
25. Neilson JR, Zheng GX, Burge CB, Sharp PA, (2007) Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev 21: 578-589.
26. Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, et al. (2007) miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129: 147-161.
27. Sonkoly E, Janson P, Majuri ML, Savinko T, Fyhrquist N, et al. (2010) MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. J Allergy Clin Immunol 126: 581-589 e581-520.
28. Yamada Y, Enokida H, Kojima S, Kawakami K, Chiyomaru T, et al. (2011) MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Sci 102: 522-529.
29. Bouillet P, O'Reilly LA, (2009) CD95, BIM and T cell homeostasis. Nat Rev Immunol 9: 514-519.
30. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, et al. (2007) Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179: 5082-5089.
31. Rivetti di Val Cervo P, Lena AM, Nicoloso M, Rossi S, Mancini M, et al. (2012) p63-microRNA feedback in keratinocyte senescence. Proc Natl Acad Sci U S A 109: 1133-1138.
32. Ma X, Kumar M, Choudhury SN, Becker Buscaglia LE, Barker JR, et al. (2011) Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis. Proc Natl Acad Sci U S A 108: 10144-10149.
33. Yuan K, Lian Z, Sun B, Clayton MM, Ng IO, et al. (2012) Role of miR-148a in hepatitis B associated hepatocellular carcinoma. PLoS One 7: e35331.
34. Lin H, Dai T, Xiong H, Zhao X, Chen X, et al. (2010) Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. PLoS One 5: e15797.
35. Kong W, He L, Coppola M, Guo J, Esposito NN, et al. (2010) MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem 285: 17869-17879.
36. Bhatti I, Lee A, James V, Hall RI, Lund JN, et al. (2011) Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. J Gastrointest Surg 15: 199-208.
37. Medina PP, Nolde M, Slack FJ, (2010) OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467: 86-90.
38. Dey N, Das F, Ghosh-Choudhury N, Mandal CC, Parekh DJ, et al. (2012) microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion. PLoS One 7: e37366.
39. Lu TX, Hartner J, Lim EJ, Fabry V, Mingler MK, et al. (2011) MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol 187: 3362-3373.
40. Song JT, Hu B, Qu HY, Bi CL, Huang XZ, et al. (2012) Mechanical Stretch Modulates MicroRNA 21 Expression, Participating in Proliferation and Apoptosis in Cultured Human Aortic Smooth Muscle Cells. PLoS One 7: e47657.
41. Zhang J, Xiao Z, Lai D, Sun J, He C, et al. (2012) miR-21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer. Br J Cancer 107: 352-359.
42. Garchow BG, Bartulos Encinas O, Leung YT, Tsao PY, Eisenberg RA, et al. (2011) Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice. EMBO Mol Med 3: 605-615.
43. Zhao JL, Rao DS, Boldin MP, Taganov KD, O'Connell RM, et al. (2011) NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc Natl Acad Sci U S A 108: 9184-9189.
44. Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, et al. (2010) Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142: 914-929.
45. Wang G, Tam LS, Li EK, Kwan BC, Chow KM, et al. (2010) Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J Rheumatol 37: 2516-2522.
46. Fenoglio C, Cantoni C, De Riz M, Ridolfi E, Cortini F, et al. (2011) Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis. Neurosci Lett 504: 9-12.
47. Li J, Wan Y, Guo Q, Zou L, Zhang J, et al. (2010) Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis. Arthritis Res Ther 12: R81.
48. Curtale G, Citarella F, Carissimi C, Goldoni M, Carucci N, et al. (2010) An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 115: 265-273.
49. Yang L, Boldin MP, Yu Y, Liu CS, Ea CK, et al. (2012) miR-146a controls the resolution of T cell responses in mice. J Exp Med 209: 1655-1670.